OpGen (OPGN) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart

OPGN Stock Forecast

OpGen stock forecast is as follows: an average price target of $0.67 (represents a -7.46% downside from OPGN’s last price of $0.72) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

OPGN Price Target

The average price target for OpGen (OPGN) is $0.67 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $0.67 to $0.67. This represents a potential -7.46% downside from OPGN's last price of $0.72.

OPGN Analyst Ratings

Buy

According to 1 Wall Street analysts, OpGen's rating consensus is 'Buy'. The analyst rating breakdown for OPGN stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

OpGen Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jul 11, 2022	Ben Haynor	Industrial Alliance Securities	$0.67	$0.61	9.25%	-7.46%

The latest OpGen stock forecast, released on Jul 11, 2022 by Ben Haynor from Industrial Alliance Securities, set a price target of $0.67, which represents a 9.25% increase from the stock price at the time of the forecast ($0.61), and a -7.46% decrease from OPGN last price ($0.72).

OpGen Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$0.72	$0.72	$0.72
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of OpGen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to OpGen's last price of $0.72. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Jul 11, 2022	Alliance Global Partners		Buy	Downgrade

OpGen's last stock rating was published by Alliance Global Partners on Jul 11, 2022. The company Downgrade its OPGN rating from "null" to "Buy".

OpGen Financial Forecast

OpGen Revenue Forecast

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Jun 16
Revenue	-	-	-	-	-	$699.02K	-	$913.44K	$721.63K	$448.71K	$967.21K	$469.75K	$1.43M	$1.24M	$811.62K	$829.72K	$1.35M	$1.06M	$1.19M	$616.93K	$820.67K	$648.22K	$1.01M	$1.02M	$846.23K	$771.77K	$1.18M
Avg Forecast	$2.10M	$1.80M	$1.50M	$1.20M	$1.00M	$900.00K	$900.00K	$1.60M	$600.00K	$400.00K	$1.00M	$1.05M	$1.40M	$1.10M	$1.13M	$1.33M	$1.30M	$1.00M	$1.20M	$600.00K	$900.00K	$900.00K	$1.02M	$1.11M	$952.00K	$607.89K	$892.97K
High Forecast	$2.10M	$1.80M	$1.50M	$1.20M	$1.00M	$900.00K	$900.00K	$1.60M	$600.00K	$400.00K	$1.00M	$1.05M	$1.40M	$1.10M	$1.13M	$1.33M	$1.30M	$1.00M	$1.20M	$600.00K	$900.00K	$900.00K	$1.02M	$1.11M	$1.14M	$729.47K	$1.07M
Low Forecast	$2.10M	$1.80M	$1.50M	$1.20M	$1.00M	$900.00K	$900.00K	$1.60M	$600.00K	$400.00K	$1.00M	$1.05M	$1.40M	$1.10M	$1.13M	$1.33M	$1.30M	$1.00M	$1.20M	$600.00K	$900.00K	$900.00K	$1.02M	$1.11M	$761.60K	$486.31K	$714.38K
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	15	9	9	16	8	10	16	18	7	8
Surprise %	-	-	-	-	-	0.78%	-	0.57%	1.20%	1.12%	0.97%	0.45%	1.02%	1.13%	0.72%	0.62%	1.04%	1.06%	0.99%	1.03%	0.91%	0.72%	0.99%	0.92%	0.89%	1.27%	1.32%

OpGen's average Quarter revenue forecast for Dec 23 based on 1 analysts is $1.00M, with a low forecast of $1.00M, and a high forecast of $1.00M. OPGN's average Quarter revenue forecast represents a 43.06% increase compared to the company's last Quarter revenue of $699.02K (Sep 23).

OpGen EBITDA Forecast

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Jun 16
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	15	9	9	16	8	10	16	18	7	8
EBITDA	-	-	-	-	-	$-3.19M	-	$-4.69M	$-4.54M	$-6.20M	$-5.26M	$-5.33M	$-5.18M	$-4.02M	$-5.15M	$-13.14M	$-5.13M	$-5.78M	$-5.74M	$-3.68M	$-2.24M	$-3.20M	$-2.33M	$-3.57M	$-2.84M	$-4.79M	$-4.86M
Avg Forecast	$-2.10M	$-1.80M	$-1.50M	$-14.86M	$-1.00M	$-900.00K	$-900.00K	$-13.51M	$-4.22M	$-400.00K	$-1.00M	$-12.28M	$-1.40M	$-1.10M	$-1.13M	$-13.14M	$-1.30M	$-1.00M	$-1.20M	$-2.36M	$-900.00K	$-900.00K	$-1.02M	$-2.37M	$-3.14M	$-3.51M	$-3.30M
High Forecast	$-2.10M	$-1.80M	$-1.50M	$-11.89M	$-1.00M	$-900.00K	$-900.00K	$-10.81M	$-3.38M	$-400.00K	$-1.00M	$-9.83M	$-1.40M	$-1.10M	$-1.13M	$-10.51M	$-1.30M	$-1.00M	$-1.20M	$-1.89M	$-900.00K	$-900.00K	$-1.02M	$-1.89M	$-2.51M	$-2.81M	$-2.64M
Low Forecast	$-2.10M	$-1.80M	$-1.50M	$-17.84M	$-1.00M	$-900.00K	$-900.00K	$-16.22M	$-5.07M	$-400.00K	$-1.00M	$-14.74M	$-1.40M	$-1.10M	$-1.13M	$-15.77M	$-1.30M	$-1.00M	$-1.20M	$-2.83M	$-900.00K	$-900.00K	$-1.02M	$-2.84M	$-3.77M	$-4.21M	$-3.96M
Surprise %	-	-	-	-	-	3.55%	-	0.35%	1.08%	15.49%	5.26%	0.43%	3.70%	3.65%	4.57%	1.00%	3.95%	5.78%	4.78%	1.56%	2.49%	3.55%	2.29%	1.51%	0.90%	1.36%	1.47%

undefined analysts predict OPGN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than OpGen's previous annual EBITDA (undefined) of $NaN.

OpGen Net Income Forecast

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Jun 16
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	15	9	9	16	8	10	16	18	7	8
Net Income	-	-	-	-	-	$-4.06M	-	$-7.02M	$-9.97M	$-14.69M	$-6.41M	$-7.76M	$-6.81M	$-6.06M	$-7.09M	$-14.85M	$-7.11M	$-7.68M	$-7.48M	$-3.95M	$-2.52M	$-3.48M	$-2.59M	$-3.85M	$-3.05M	$-4.98M	$-5.05M
Avg Forecast	$-9.25M	$-10.57M	$-11.23M	$-16.80M	$-16.51M	$-28.40M	$-46.89M	$-15.27M	$-4.56M	$-32.17M	$-40.21M	$-13.89M	$-41.55M	$-50.93M	$-52.27M	$-14.85M	$-83.10M	$-96.50M	$-136.71M	$-2.53M	$-217.13M	$-1.04B	$-911.39M	$-2.55M	$-3.37M	$-3.65M	$-3.43M
High Forecast	$-9.25M	$-10.57M	$-11.23M	$-13.44M	$-16.51M	$-28.40M	$-46.89M	$-12.22M	$-3.65M	$-32.17M	$-40.21M	$-11.11M	$-41.55M	$-50.93M	$-52.27M	$-11.88M	$-83.10M	$-96.50M	$-136.71M	$-2.03M	$-217.13M	$-1.04B	$-911.39M	$-2.04M	$-2.70M	$-2.92M	$-2.74M
Low Forecast	$-9.25M	$-10.57M	$-11.23M	$-20.16M	$-16.51M	$-28.40M	$-46.89M	$-18.33M	$-5.47M	$-32.17M	$-40.21M	$-16.66M	$-41.55M	$-50.93M	$-52.27M	$-17.82M	$-83.10M	$-96.50M	$-136.71M	$-3.04M	$-217.13M	$-1.04B	$-911.39M	$-3.06M	$-4.05M	$-4.38M	$-4.11M
Surprise %	-	-	-	-	-	0.14%	-	0.46%	2.19%	0.46%	0.16%	0.56%	0.16%	0.12%	0.14%	1.00%	0.09%	0.08%	0.05%	1.56%	0.01%	0.00%	0.00%	1.51%	0.90%	1.36%	1.47%

OpGen's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OPGN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

OpGen SG&A Forecast

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Jun 16
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	15	9	9	16	8	10	16	18	7	8
SG&A	-	-	-	-	-	$2.37M	-	$3.45M	$3.20M	$3.05M	$3.30M	$3.68M	$3.50M	$3.09M	$3.49M	$3.56M	$3.09M	$3.29M	$3.54M	$1.98M	$1.67M	$1.94M	$1.99M	$2.12M	$2.12M	$3.07M	$3.37M
Avg Forecast	$6.91M	$5.92M	$4.94M	$3.95M	$3.29M	$2.96M	$2.96M	$5.26M	$1.97M	$1.32M	$3.29M	$3.45M	$4.61M	$3.62M	$3.70M	$4.38M	$4.28M	$3.29M	$3.95M	$1.97M	$2.96M	$2.96M	$3.34M	$3.65M	$3.13M	$2.00M	$2.94M
High Forecast	$6.91M	$5.92M	$4.94M	$3.95M	$3.29M	$2.96M	$2.96M	$5.26M	$1.97M	$1.32M	$3.29M	$3.45M	$4.61M	$3.62M	$3.70M	$4.38M	$4.28M	$3.29M	$3.95M	$1.97M	$2.96M	$2.96M	$3.34M	$3.65M	$3.76M	$2.40M	$3.53M
Low Forecast	$6.91M	$5.92M	$4.94M	$3.95M	$3.29M	$2.96M	$2.96M	$5.26M	$1.97M	$1.32M	$3.29M	$3.45M	$4.61M	$3.62M	$3.70M	$4.38M	$4.28M	$3.29M	$3.95M	$1.97M	$2.96M	$2.96M	$3.34M	$3.65M	$2.51M	$1.60M	$2.35M
Surprise %	-	-	-	-	-	0.80%	-	0.66%	1.62%	2.32%	1.00%	1.06%	0.76%	0.85%	0.94%	0.81%	0.72%	1.00%	0.90%	1.00%	0.57%	0.65%	0.59%	0.58%	0.68%	1.54%	1.15%

OpGen's average Quarter SG&A projection for Dec 23 is $3.29M, based on 1 Wall Street analysts, with a range of $3.29M to $3.29M. The forecast indicates a 38.77% rise compared to OPGN last annual SG&A of $2.37M (Sep 23).

OpGen EPS Forecast

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Jun 16
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	15	9	9	16	8	10	16	18	7	8
EPS	-	-	-	-	-	$-0.46	-	$-1.53	$-4.08	$-6.17	$-2.75	$-3.34	$-3.37	$-0.16	$-0.19	$-0.50	$-0.34	$-0.40	$-0.49	$-0.53	$-0.61	$-3.95	$-3.00	$-8.20	$-15.00	$-95.00	$-190.00
Avg Forecast	$-1.40	$-1.60	$-1.70	$-1.90	$-2.50	$-4.30	$-7.10	$-12.00	$-20.00	$-24.00	$-30.00	$-32.00	$-31.00	$-38.00	$-39.00	$-48.00	$-62.00	$-72.00	$-102.00	$-78.00	$-162.00	$-778.00	$-680.00	$-1.23K	$-18.60	$-2.75	$-4.75
High Forecast	$-1.40	$-1.60	$-1.70	$-1.90	$-2.50	$-4.30	$-7.10	$-12.00	$-20.00	$-24.00	$-30.00	$-32.00	$-31.00	$-38.00	$-39.00	$-48.00	$-62.00	$-72.00	$-102.00	$-78.00	$-162.00	$-778.00	$-680.00	$-1.23K	$-14.88	$-2.20	$-3.80
Low Forecast	$-1.40	$-1.60	$-1.70	$-1.90	$-2.50	$-4.30	$-7.10	$-12.00	$-20.00	$-24.00	$-30.00	$-32.00	$-31.00	$-38.00	$-39.00	$-48.00	$-62.00	$-72.00	$-102.00	$-78.00	$-162.00	$-778.00	$-680.00	$-1.23K	$-22.32	$-3.30	$-5.70
Surprise %	-	-	-	-	-	0.11%	-	0.13%	0.20%	0.26%	0.09%	0.10%	0.11%	0.00%	0.00%	0.01%	0.01%	0.01%	0.00%	0.01%	0.00%	0.01%	0.00%	0.01%	0.81%	34.55%	40.00%

According to undefined Wall Street analysts, OpGen's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OPGN previous annual EPS of $NaN (undefined).

OpGen Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
BJDX	Bluejay Diagnostics	$4.38	$10.00	128.31%	Buy
SGHT	Sight Sciences	$3.62	$7.50	107.18%	Hold
NPCE	NeuroPace	$11.52	$15.00	30.21%	Buy
HSCS	Heart Test Laboratories	$3.85	$3.00	-22.08%	Buy

OPGN Forecast FAQ

Is OpGen a good buy?

Yes, according to 1 Wall Street analysts, OpGen (OPGN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of OPGN's total ratings.

What is OPGN's price target?

OpGen (OPGN) average price target is $0.67 with a range of $0.67 to $0.67, implying a -7.46% from its last price of $0.724. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will OpGen stock go up soon?

According to Wall Street analysts' prediction for OPGN stock, the company can go down by -7.46% (from the last price of $0.724 to the average price target of $0.67), down by -7.46% based on the highest stock price target, and down by -7.46% based on the lowest stock price target.

Can OpGen stock reach $1?

OPGN's average twelve months analyst stock price target of $0.67 does not support the claim that OpGen can reach $1 in the near future.

What are OpGen's analysts' financial forecasts?

OpGen's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $4.4M (high $4.4M, low $4.4M), average EBITDA is $-16.313M (high $-13.611M, low $-19.016M), average net income is $-107M (high $-104M, low $-110M), average SG&A $14.48M (high $14.48M, low $14.48M), and average EPS is $-25.9 (high $-25.9, low $-25.9). OPGN's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $6.6M (high $6.6M, low $6.6M), average EBITDA is $-20.264M (high $-17.292M, low $-23.237M), average net income is $-47.839M (high $-44.479M, low $-51.199M), average SG&A $21.71M (high $21.71M, low $21.71M), and average EPS is $-6.6 (high $-6.6, low $-6.6).

Did the OPGN's actual financial results beat the analysts' financial forecasts?

Based on OpGen's last annual report (Dec 2022), the company's revenue was $2.61M, which missed the average analysts forecast of $3.05M by -14.51%. Apple's EBITDA was $-22.172M, beating the average prediction of $-17.909M by 23.80%. The company's net income was $-36.743M, missing the average estimation of $-90.819M by -59.54%. Apple's SG&A was $13.23M, beating the average forecast of $10.03M by 31.83%. Lastly, the company's EPS was $-15.05, missing the average prediction of $-106 by -85.80%. In terms of the last quarterly report (Sep 2023), OpGen's revenue was $699.02K, missing the average analysts' forecast of $900K by -22.33%. The company's EBITDA was $-3.192M, beating the average prediction of $-900K by 254.66%. OpGen's net income was $-4.063M, missing the average estimation of $-28.396M by -85.69%. The company's SG&A was $2.37M, missing the average forecast of $2.96M by -19.93%. Lastly, the company's EPS was $-0.46, missing the average prediction of $-4.3 by -89.30%